KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Co-Diagnostics (CODX) Capital Expenditures (2017 - 2025)

Historic Capital Expenditures for Co-Diagnostics (CODX) over the last 9 years, with Q3 2025 value amounting to $75105.0.

  • Co-Diagnostics' Capital Expenditures fell 5694.58% to $75105.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $641065.0, marking a year-over-year decrease of 4376.46%. This contributed to the annual value of $748352.0 for FY2024, which is 4518.8% down from last year.
  • Latest data reveals that Co-Diagnostics reported Capital Expenditures of $75105.0 as of Q3 2025, which was down 5694.58% from $401060.0 recorded in Q2 2025.
  • Co-Diagnostics' Capital Expenditures' 5-year high stood at $507560.0 during Q2 2022, with a 5-year trough of $72987.0 in Q4 2024.
  • In the last 5 years, Co-Diagnostics' Capital Expenditures had a median value of $230048.0 in 2022 and averaged $251511.1.
  • Per our database at Business Quant, Co-Diagnostics' Capital Expenditures tumbled by 8429.04% in 2024 and then skyrocketed by 30663.5% in 2025.
  • Co-Diagnostics' Capital Expenditures (Quarter) stood at $121755.0 in 2021, then skyrocketed by 140.9% to $293304.0 in 2022, then soared by 58.4% to $464602.0 in 2023, then crashed by 84.29% to $72987.0 in 2024, then increased by 2.9% to $75105.0 in 2025.
  • Its Capital Expenditures was $75105.0 in Q3 2025, compared to $401060.0 in Q2 2025 and $91913.0 in Q1 2025.